The University Health Network,
where “above all else the needs of patients come first”, encompasses Toronto Rehabilitation Institute, Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre and the Michener Institute of Education at UHN . The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of groundbreaking firsts and a purpose of “Transforming lives and communities through excellence in care, discovery and learning”, the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,600 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.
University Health Network (UHN) is a research hospital affiliated with the University of Toronto and a member of the Toronto Academic Health Science Network. The scope of research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. Research across UHN’s seven research institutes spans the full spectrum of diseases and disciplines, including cancer, cardiovascular sciences, transplantation, neural and sensory sciences, musculoskeletal health, rehabilitation sciences, and community and population health. Find out about our purpose, values and principles here.
The Schroeder Arthritis Institute at University Health Network is among the leading arthritis research enterprises bringing together our scientists, educators and clinicians to discover, to educate and to transform patient care. We are focused on developing new treatments, diagnostic tests, and models of care, all with the goal of improving the lives of millions of patients living with arthritis. We have assembled a team of innovative arthritis researchers, clinician-scientists and educators who are global leaders in their fields. The institute is home to one of world’s largest tissue biobanks and clinical cohorts for arthritis. We employ high throughput technologies such as gene sequencing, metabolic and inflammatory profiling, and imaging, coupled with artificial intelligence to understand disease mechanisms, for the development of novel biomarkers and the discovery of new therapies.
To learn more about the institute and Kapoor Lab, please visit: Schroeder Arthritis Institute and http://www.kapoorlab.ca/
We are seeking a highly motivated Postdoctoral Fellow to join at the Schroeder Arthritis Institute to conduct cutting-edge biomarker and therapeutic target exploration research using high throughput techniques (such as RNA sequencing and single cell sequencing) in animal models of osteoarthritis as well as human OA biospecimens. The postdoctoral research fellow will work under the direction of the Principal Investigator and will be supported by research staff from basic science and clinical research backgrounds. Competency in animal models of osteoarthritis and omic technologies is required. Strong communication and scientific writing skills for contributing to manuscript publication and grant writing is vital.
• Ph.D. awarded within the past 5 years
• Has published peer reviewed articles in the field of Osteoarthritis
• Prior expertise in osteoarthritis research, animal models of osteoarthritis and osteoarthritis histopathology required
• Strong familiarity with laboratory techniques including ELISA/multiplex assaying, high-throughput sequencing, flow cytometry and immunohistochemistry
• Excellent understanding of the molecular disease pathology of osteoarthritis considered a distinct advantage
• Detail-oriented and well organized
• Excellent verbal and written communication skills
• Computer literacy (Outlook, Word, Excel, Power Point, Adobe Photoshop/Illustrator)
• Ability to work both independently and as part of a team